First developed in 1992, immuno-PCR combines an ELISA (enzyme-linked immunosorbent assay) with PCR (polymerase chain reaction) to offer a significant increase in sensitivity compared with traditional ...

Allied Market Research published a report, titled, “Immuno-oncology Assay Market by Product (Consumables and Software), by Technology (Immunoassays, Polymerase Chain Reaction (PCR), Next-Generation ...

Antibody conjugates are widely used as diagnostics and imaging reagents. However, many such conjugates suffer losses in sensitivity and specificity due to nonspecific labeling techniques. We have ...

Traumatic brain injury, together with adjacent brain conditions such as Alzheimer’s disease, is a global health crisis. In this presentation, Aleksandra Hemm, Product Manager from Thermo Fisher ...

The detection of tyrosinase mRNA in sentinel lymph nodes (SLNs) by reverse transcription polymerase chain reaction (RT-PCR) is a sensitive indicator for the presence of melanoma or nevus cells, but it ...

Combining target recognition by two aptamers, enzymatic ligation, and PCR, the proximity ligation method enables the detection of minute amounts of proteins. Thousands of proteins with potential ...

Pune, Maharashtra, India, September 15 2020 (Wiredrelease) Allied Analytics –:Immuno-oncology Assay Market size accounted for $2,769 million in 2018, and is expected to reach 6,179 million by 2026, ...

The immuno-oncology assay market has been witnessing significant growth in recent years, driven by advancements in cancer immunotherapy and the increasing incidence of cancer worldwide.

Like many researchers who had to run hundreds of Southern blots, I felt immediate relief the first time I used PCR for genotyping. It was no longer going to take seven days to see results, and I would ...